Pazelliptine
Alternative Names: BD 40; NSC 303565; NSC 3274714D; SR 95225ALatest Information Update: 08 Dec 1994
At a glance
- Originator Nonindustrial source
- Developer Sanofi-Synthelabo
- Class Antineoplastics; Antiretrovirals; Indoles; Isoquinolines; Small molecules
- Mechanism of Action DNA cross linking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 08 Dec 1994 Discontinued-II for Cancer in France (IV)